Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Int J Nanomedicine
; 15: 7601-7613, 2020.
Article
in En
| MEDLINE
| ID: mdl-33116490
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Compounding
/
Etoposide
/
Nanoparticles
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
Language:
En
Journal:
Int J Nanomedicine
Year:
2020
Document type:
Article